0 Commentaires
0 Parts
1KB Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Marketplace
-
Forums
-
Connectez-vous pour aimer, partager et commenter!
-
Preclinical Support with Advanced Coronavirus Animal Model Services for Antiviral ResearchThe Coronavirus Disease 2019 (COVID-19) pandemic has led to the rapid development of animal models to help us understand the disease's pathogenesis, test treatments and support vaccine development. Models previously established for studying severe acute respiratory syndrome coronavirus (SARS-CoV) have been rapidly adapted for SARS-CoV-2 research. However, despite both viruses utilizing ACE2 as...0 Commentaires 0 Parts 29 Vue 0 Aperçu
-
Asia-Pacific PDX Models Market Expands Through Precision Oncology ResearchAsia-Pacific Patient Derived Xenograft (PDX) Models Market Summary: According to the latest report published by Data Bridge Market Research, the Asia-Pacific Patient Derived Xenograft (PDX) Models Market CAGR Value The world-class Asia-Pacific Patient Derived Xenograft (PDX) Models Market report analyses some of the challenges that Asia-Pacific Patient Derived Xenograft (PDX) Models...0 Commentaires 0 Parts 407 Vue 0 Aperçu
-
In Vivo CRO Market to Reach USD 10.07 Billion by 2033, Driven by Growing Global Research StandardsThe global in vivo CRO market size was valued at USD 4.95 billion in 2024, and it is projected to reach USD 5.36 billion in 2025 to USD 10.07 billion by 2033, growing at a CAGR of 8.2% during the forecast period (2025–2033). The rising international standards adoption by contract researchers in emerging nations is projected to improve demand for...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
In Vivo Toxicology Market to Reach USD 6.37 Billion by 2031 | CAGR 6.1%According to a newly published market research report by 24LifeSciences, the global In Vivo Toxicology market was valued at USD 4.27 billion in 2024 and is projected to reach USD 6.37 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period 20252031. In Vivo Toxicology represents an essential component of preclinical drug development, employing whole...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
In Vivo Toxicology Market to Reach USD 6.37 Billion by 2031 | CAGR 6.1%According to a newly published market research report by 24LifeSciences, the global In Vivo Toxicology market was valued at USD 4.27 billion in 2024 and is projected to reach USD 6.37 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period 20252031. In Vivo Toxicology represents an essential component of preclinical drug development, employing whole...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Is In-Vivo Imaging Advancing Research in Small Animal Models?Small Animal Imaging (In-Vivo) Market Summary: According to the latest report published by Data Bridge Market Research, the Small Animal Imaging (In-Vivo) Market CAGR Value All the statistical data including facts and figures that are included in the trustworthy Small Animal Imaging (In-Vivo) Market report is represented by using several charts, graphs or tables. This...0 Commentaires 0 Parts 620 Vue 0 Aperçu
-
Tumor Mice Model Market Size to Reach USD 2.92 Billion by 2031 at 7.1% CAGR: Key Players, Growth Trends, and Forecast InsightsTumor mice model market is witnessing sustained growth as oncology research intensifies and pharmaceutical companies seek more predictive preclinical platforms. Valued at USD 1.82 billion in 2024, the market is projected to reach USD 2.92 billion by 2031, expanding at a compound annual growth rate (CAGR) of 7.1% during the forecast period from 2025 to 2032. Discover Market Highlights –...0 Commentaires 0 Parts 738 Vue 0 Aperçu
-
Tumor Mice Model Market Size to Reach USD 2.92 Billion by 2031 at 7.1% CAGR: Key Players, Growth Trends, and Forecast InsightsTumor mice model market is witnessing sustained growth as oncology research intensifies and pharmaceutical companies seek more predictive preclinical platforms. Valued at USD 1.82 billion in 2024, the market is projected to reach USD 2.92 billion by 2031, expanding at a compound annual growth rate (CAGR) of 7.1% during the forecast period from 2025 to 2032. Discover Market Highlights –...0 Commentaires 0 Parts 766 Vue 0 Aperçu
Commandité
Commandité
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek